HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive gene testing for Huntington disease and other neurodegenerative disorders.

AbstractBACKGROUND:
Controversies exist around predictive testing (PT) programmes in neurodegenerative disorders.
AIMS:
This study sets out to answer the following questions relating to Huntington disease (HD) and other neurodegenerative disorders: differences between these patients in their PT journeys, why and when individuals withdraw from PT, and decision-making processes regarding reproductive genetic testing.
METHODS:
A case series analysis of patients having PT from the multidisciplinary Western Australian centre for PT over the past 20 years was performed using internationally recognised guidelines for predictive gene testing in neurodegenerative disorders.
RESULTS:
Of 740 at-risk patients, 518 applied for PT: 466 at risk of HD, 52 at risk of other neurodegenerative disorders - spinocerebellar ataxias, hereditary prion disease and familial Alzheimer disease. Thirteen percent withdrew from PT - 80.32% of withdrawals occurred during counselling stages. Major withdrawal reasons related to timing in the patients' lives or unknown as the patient did not disclose the reason. Thirty-eight HD individuals had reproductive genetic testing: 34 initiated prenatal testing (of which eight withdrew from the process) and four initiated pre-implantation genetic diagnosis. There was no recorded or other evidence of major psychological reactions or suicides during PT.
CONCLUSIONS:
People withdrew from PT in relation to life stages and reasons that are unknown. Our findings emphasise the importance of: (i) adherence to internationally recommended guidelines for PT; (ii) the role of the multidisciplinary team in risk minimisation; and (iii) patient selection.
AuthorsS Wedderburn, P K Panegyres, S Andrew, J Goldblatt, T Liebeck, F McGrath, M Wiltshire, C Pestell, J Lee, J Beilby
JournalInternal medicine journal (Intern Med J) Vol. 43 Issue 12 Pg. 1272-9 (Dec 2013) ISSN: 1445-5994 [Electronic] Australia
PMID23654213 (Publication Type: Journal Article)
Copyright© 2013 The Authors; Internal Medicine Journal © 2013 Royal Australasian College of Physicians.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Decision Making
  • Female
  • Genetic Testing (methods, standards)
  • Humans
  • Huntington Disease (diagnosis, epidemiology, genetics)
  • Male
  • Middle Aged
  • Neurodegenerative Diseases (diagnosis, epidemiology, genetics)
  • Predictive Value of Tests
  • Retrospective Studies
  • Western Australia (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: